Lucosky Brookman and Sheppard Mullin have advised Tharimmune. Paul Hastings has advised Clear Street. Reed Smith has advised DRW. Tharimmune, Inc. (NASDAQ: THAR), a publicly traded...
Tharimmune Raises $545 Million in Private Placement to Acquire Canton Coin and Expand Blockchain Adoption
Aardvark Therapeutics’ $94.2 Million Initial Public Offering
Paul Hastings advised Aardvark Therapeutics on the offering. Aardvark Therapeutics, Inc. announced its approximately $94.2 million IPO on the Nasdaq Global Select Market. The offering comprises...
Xencor’s $175 Million Common Stock Underwritten Public Offering
Paul Hastings LLP advised Xencor, Inc. on the offering. Xencor, Inc. (Nasdaq: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and...